| Date Filed | Type | Description |
| 07/07/2015 |
SC 13G/A
| PERKINS CAPITAL MANAGEMENT INC reports a 0% stake in Uroplasty, Inc. |
| 07/07/2015 |
SC 13G/A
| PERKINS CAPITAL MANAGEMENT INC reports a 0% stake in Uroplasty, Inc. |
| 04/01/2015 |
SC 13D/A
| UROPLASTY INC reports a 0% stake in Cogentix Medical, Inc. |
| 03/31/2015 |
8-K
| Form 8-K - Current report |
| 03/10/2015 |
8-K
| Investor presentation |
| 03/10/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 03/10/2015 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/03/2015 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"MINNEAPOLIS, March 3, 2015 -- Uroplasty, Inc. , a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, will host a meeting for shareholders and analysts on Thursday, March 12, 2015, beginning at 3:00 pm Central Time, at Uroplasty’s corporate headquarters in Minnetonka, Minnesota. Rob Kill, President and Chief Executive Officer, will host the meeting, which will feature a discussion of the proposed merger between Uroplasty and Vision-Sciences and a presentation by Dr. Roland Ugarte, who will discuss the roles that Urgent PC and EndoSheath have in today’s urology practices. Dr. Ugarte is a Senior Partner of Urology Associates, a Minneapolis-based group of 15 urologic surgeons providing comprehensive care to over 75,000 ..." |
|
| 03/03/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 02/23/2015 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
| 02/17/2015 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 6.2% stake in Uroplasty, Inc. |
| 02/13/2015 |
SC 13G/A
| Visium Asset Management, LP reports a 0% stake in Uroplasty, Inc. |
| 02/10/2015 |
SC 13G/A
| MASSACHUSETTS FINANCIAL SERVICES CO reports a 0% stake in Uroplasty, Inc. |
| 02/10/2015 |
SC 13G/A
| MASSACHUSETTS FINANCIAL SERVICES CO reports a 10.1% stake in Uroplasty, Inc. |
| 02/06/2015 |
10-Q
| Quarterly Report for the period ended December 31, 2014 |
| 02/04/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 01/28/2015 |
SC 13G/A
| PERKINS CAPITAL MANAGEMENT INC reports a 5.8% stake in Uroplasty, Inc. |
| 01/27/2015 |
8-K
| Other Events |
| 01/27/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 01/26/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 01/23/2015 |
SC 13G
| Amici Capital, LLC reports a 6.8% stake in Uroplasty, Inc. |
| 01/22/2015 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits|
Docs:
|
"MINNEAPOLIS, January 22, 2015 -- Uroplasty, Inc. , a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fiscal 2015 third quarter ended December 31, 2014. Global revenue for the Company’s Urgent ® PC Neuromodulation System grew 14.5% to $4.4 million, a new quarterly revenue record, as compared to $3.9 million in the third quarter of the prior year. Global Macroplastique sales were $2.0 million during the third quarter as compared to $2.3 million in the third quarter of fiscal 2014. Total revenue for the third quarter of fiscal 2015 was $6.7 million, a 4.2% increase from the same quarter in the prior year. The impact of changes in foreign currency exchange rates negatively imp..." |
|
| 01/12/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 12/31/2014 |
SC 13D
| UROPLASTY INC reports a 61.4% stake in Vision-Sciences, Inc. |
| 12/23/2014 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 12/22/2014 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 12/22/2014 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 12/22/2014 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 12/22/2014 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 12/22/2014 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 12/22/2014 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 12/22/2014 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 12/22/2014 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 12/22/2014 |
425
| Form 425 - Prospectuses and communications, business combinations |
|